Earnings NewsHealthcareEpizyme beats by $0.12, misses on revenueMar. 09, 2016 6:32 AM ETIpsen S.A. (IPSEY) StockBy: SA News Team Epizyme (NASDAQ:EPZM): Q4 EPS of -$0.53 beats by $0.12. Revenue of $0.56M (-94.6% Y/Y) misses by $0.01M. Press Release Recommended For YouMore Trending NewsSee More »About IPSEY StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgIPSEY--Ipsen S.A.Trending AnalysisTrending News